| 000 | 01708 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514035027.0 | ||
| 264 | 0 | _c20020724 | |
| 008 | 200207s 0 0 eng d | ||
| 022 | _a0041-008X | ||
| 024 | 7 |
_a10.1006/taap.2002.9418 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuo, T L | |
| 245 | 0 | 0 |
_aGenistein modulates splenic natural killer cell activity, antibody-forming cell response, and phenotypic marker expression in F(0) and F(1) generations of Sprague-Dawley rats. _h[electronic resource] |
| 260 |
_bToxicology and applied pharmacology _cJun 2002 |
||
| 300 |
_a219-27 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticarcinogenic Agents _xpharmacology |
| 650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenistein _xpharmacology |
| 650 | 0 | 4 |
_aImmunoglobulin M _xbiosynthesis |
| 650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOrgan Size _xdrug effects |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSpleen _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 700 | 1 | _aWhite, K L | |
| 700 | 1 | _aBrown, R D | |
| 700 | 1 | _aDelclos, K B | |
| 700 | 1 | _aNewbold, R R | |
| 700 | 1 | _aWeis, C | |
| 700 | 1 | _aGermolec, D R | |
| 700 | 1 | _aMcCay, J A | |
| 773 | 0 |
_tToxicology and applied pharmacology _gvol. 181 _gno. 3 _gp. 219-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/taap.2002.9418 _zAvailable from publisher's website |
| 999 |
_c11974189 _d11974189 |
||